Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03514121
Title FPA150 in Patients With Advanced Solid Tumors
Acronym FPA150-001
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Five Prime Therapeutics, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Honor Health Scottsdale Arizona 85258 United States Details
Cedars-Sinai Medical Center Los Angeles California 90048 United States Details
UCLA Los Angeles California 90095 United States Details
Sarcoma Oncology Research Center Santa Monica California 90403 United States Details
Yale Cancer Center New Haven Connecticut 06520 United States Details
Orchard Healthcare Research Inc. Skokie Illinois 60077 United States Details
Karmanos Cancer Institute Detroit Michigan 48201 United States Details
Stephenson Cancer Center Oklahoma City Oklahoma 73104 United States Details
Sarah Cannon Research Institute Nashville Tennessee 37203 United States Details
The University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
South Texas Accelerated Research Therapeutics San Antonio Texas 78229 United States Details
Utah Cancer Specialists Salt Lake City Utah 84106 United States Details
Medical Oncology Associates, PS Spokane Washington 99208 United States Details
National Cancer Center Gyeonggi-do 10408 Korea, Republic of Details
Seoul National University Bundang Hospital Gyeonggi-do 13620 Korea, Republic of Details
Severance Hospital Seoul 03722 Korea, Republic of Details
ASAN Medical Center Seoul 05505 Korea, Republic of Details
Samsung Medical Center Seoul 06351 Korea, Republic of Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field